For Life Sciences
For the Point of Care
Company
Resources
Publications
Contact us
Skip to content
New and Noteworthy
Machine learning
Topics
Machine learning
Publications
Real-world evidence
Artificial intelligence
Methodology
Non-small cell lung cancer
Technology & engineering
Flatiron stories
Data science
Prostate cancer
Data management
Breast cancer
Quality improvement
Point of care
Quality reporting
Regulatory
Health equity
Precision medicine
Metastatic breast cancer
Comparative effectiveness
Multiple myeloma
Post marketing requirements
Head and neck cancer
Tumor agnostic
Small cell lung cancer
Colorectal cancer
Drug discovery
Clinical research
Clinical decision support
Flatiron events
Content type
Publication summary
Article
Event recap
Webinar
Video
Press releases
Clear
Apply filter
Showing 9 of
0
results
From plenary to practice: A large language model (LLM)-based thematic analysis of landmark clinical trial discussions and factors influencing their real-world adoption
ASCO Annual Meeting
Publication summary
Publications
Machine learning
Artificial intelligence
Using ML to predict rapid progression for patients (pts) with HR+/HER2- metastatic breast cancer (mBC) treated with frontline (1L) CDK 4/6 inhibitors (CDK 4/6i)
ASCO Annual Meeting
Publication summary
Publications
Precision medicine
Machine learning
Metastatic breast cancer
Artificial intelligence
External validation of a deep learning CT biomarker to predict first-line immune checkpoint inhibitor monotherapy-associated survival in PD-L1–high metastatic non–small cell lung cancer
ASCO Annual Meeting
Publication summary
Publications
Precision medicine
Machine learning
Non-small cell lung cancer
Artificial intelligence
Machine learning risk stratification in a US-based database to identify subgroups of patients with PD-L1-high NSCLC who benefit from adding chemotherapy to pembrolizumab
ASCO Annual Meeting
Publication summary
Publications
Machine learning
Comparative effectiveness
Non-small cell lung cancer
Artificial intelligence
Machine learning risk stratification in a US-based database to identify subgroups of patients with head and neck cancer who benefit from adding chemotherapy to pembrolizumab
ASCO Annual Meeting
Publication summary
Publications
Machine learning
Comparative effectiveness
Head and neck cancer
Artificial intelligence
Unlocking the next level of RWD: Flatiron’s Scientific Vision
Real-world evidence
Data science
Machine learning
Artificial intelligence
The real-world perspective: Why global RWE matters in modern oncology
Real-world evidence
Machine learning
Prostate cancer
Artificial intelligence
High-quality, validated AI-enabled research: Insights from recent prostate cancer research
Real-world evidence
Machine learning
Quality reporting
Prostate cancer
Artificial intelligence
Flatiron Health announces 18 research acceptances featuring the company's real-world data to be presented at ISPOR 2026
Machine learning
Press releases
View more